Ads

 

Ads

 

Ads

 

World Top 100 HealthCare Products Companies List by Market Cap as of August 2026

World Top 100 HealthCare Products Companies List by Market Cap as of August 2026, World Biggest 100 HealthCare Products Companies by Market Cap, World Largest 100 HealthCare Products Companies in the World by market cap as of August 2026.

Metatag Title
World Largest HealthCare Products Companies in 2026
Metatag Abstract
World Top HealthCare Products Companies by Market Cap in 2026, World Largest HealthCare Products Companies by Market Cap in 2026.
  1. Peptidream

    World Rank (Aug-2026)
    9,690
    Market Cap (Aug-2026)
    0.902 Billion USD
    World Rank (Jan-05-2024)
    7,512
    Market Cap (Jan-05-2024)
    1.258 Billion USD
    World Rank (Jul-30-2023)
    6,400
    Market Cap (Jul-30-2023)
    1.676 Billion USD
    World Rank (Dec-25-2022)
    6,147
    Market Cap (Dec-25-2022)
    1.649 Billion USD
    World Rank (Jan-07-2022)
    5,361
    Market Cap (Jan-07-2022)
    2.59 Billion USD
    Annual Revenue in USD
    68 Million USD
    Annual Net Income in USD
    26 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    PeptiDream is a Biopharmaceutical company. It is the platform which enables the production of highly diverse non standard peptide libraries with high efficiency for the identification of highly potent and selective hit candidates which then can be developed into peptide based, small molecule based or peptide drug conjugate based therapeutics. The headquarters is in Japan.
  2. Hunan Er-Kang Pharmaceutical Co. Ltd

    World Rank (Aug-2026)
    9,735
    Market Cap (Aug-2026)
    0.892 Billion USD
    World Rank (Jan-05-2024)
    9,035
    Market Cap (Jan-05-2024)
    0.918 Billion USD
    World Rank (Jul-30-2023)
    8,972
    Market Cap (Jul-30-2023)
    0.952 Billion USD
    World Rank (Dec-25-2022)
    8,158
    Market Cap (Dec-25-2022)
    1.048 Billion USD
    World Rank (Jan-07-2022)
    7,530
    Market Cap (Jan-07-2022)
    1.47 Billion USD
    Headquarters Country
  3. Beijing Konruns Pharmaceutical

    World Rank (Aug-2026)
    9,749
    Market Cap (Aug-2026)
    0.892 Billion USD
    World Rank (Jan-05-2024)
    9,594
    Market Cap (Jan-05-2024)
    0.828 Billion USD
    World Rank (Jul-30-2023)
    9,931
    Market Cap (Jul-30-2023)
    0.800 Billion USD
    World Rank (Dec-25-2022)
    11,487
    Market Cap (Dec-25-2022)
    0.579 Billion USD
    World Rank (Jan-07-2022)
    10,686
    Market Cap (Jan-07-2022)
    0.80 Billion USD
    Headquarters Country
  4. Huaren Pharmaceutical

    World Rank (Aug-2026)
    9,780
    Market Cap (Aug-2026)
    0.892 Billion USD
    World Rank (Jan-05-2024)
    10,550
    Market Cap (Jan-05-2024)
    0.701 Billion USD
    World Rank (Jul-30-2023)
    10,867
    Market Cap (Jul-30-2023)
    0.676 Billion USD
    World Rank (Dec-25-2022)
    9,836
    Market Cap (Dec-25-2022)
    0.765 Billion USD
    World Rank (Jan-07-2022)
    10,212
    Market Cap (Jan-07-2022)
    0.87 Billion USD
    Headquarters Country
  5. Amphastar Pharmaceuticals

    World Rank (Aug-2026)
    9,798
    Market Cap (Aug-2026)
    0.889 Billion USD
    World Rank (Jan-05-2024)
    4,332
    Market Cap (Jan-05-2024)
    3.040 Billion USD
    World Rank (Jul-30-2023)
    4,422
    Market Cap (Jul-30-2023)
    2.937 Billion USD
    World Rank (Dec-25-2022)
    6,890
    Market Cap (Dec-25-2022)
    1.386 Billion USD
    World Rank (Jan-07-2022)
    8,516
    Market Cap (Jan-07-2022)
    1.20 Billion USD
    Annual Revenue in USD
    720 Million USD
    Annual Operating Income in USD
    140 Million USD
    Annual Net Income in USD
    98 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Amphastar Pharmaceuticals is a Specialty Pharmaceutical company that is engaged in the development, manufacture and marketing of generic and proprietary injectable, intranasal and inhalation products. It produce over 20 commercial products while continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. The headquarters is in USA.
  6. Chongqing Pharscin Pharmaceutical

    World Rank (Aug-2026)
    9,823
    Market Cap (Aug-2026)
    0.885 Billion USD
    World Rank (Jan-05-2024)
    8,532
    Market Cap (Jan-05-2024)
    1.008 Billion USD
    World Rank (Jul-30-2023)
    9,379
    Market Cap (Jul-30-2023)
    0.881 Billion USD
    World Rank (Dec-25-2022)
    7,535
    Market Cap (Dec-25-2022)
    1.199 Billion USD
    World Rank (Jan-07-2022)
    9,470
    Market Cap (Jan-07-2022)
    1.00 Billion USD
    Headquarters Country
  7. Theravance Biopharma

    World Rank (Aug-2026)
    9,844
    Market Cap (Aug-2026)
    0.881 Billion USD
    World Rank (Jan-05-2024)
    11,722
    Market Cap (Jan-05-2024)
    0.577 Billion USD
    World Rank (Jul-30-2023)
    11,975
    Market Cap (Jul-30-2023)
    0.565 Billion USD
    World Rank (Dec-25-2022)
    9,878
    Market Cap (Dec-25-2022)
    0.761 Billion USD
    World Rank (Jan-07-2022)
    9,685
    Market Cap (Jan-07-2022)
    0.96 Billion USD
    Headquarters Country
  8. Zogenix

    World Rank (Aug-2026)
    9,904
    World Rank (Jan-05-2024)
    9,904
    World Rank (Jul-30-2023)
    9,904
    World Rank (Dec-25-2022)
    9,904
    World Rank (Jan-07-2022)
    9,904
    Market Cap (Jan-07-2022)
    0.92 Billion USD
    Annual Revenue in USD
    75 Million USD
    Annual Operating Income in USD
    -224 Million USD
    Annual Net Income in USD
    -227 Million USD
    Annual Results for Period Ending
    For year ending December-2021
    Headquarters Country
    Company Profile
    Zogenix is a Pharmaceutical company. The headquarters is in USA.
  9. Five Prime Therapeutics

    World Rank (Aug-2026)
    9,919
    World Rank (Jan-05-2024)
    9,919
    World Rank (Jul-30-2023)
    9,919
    World Rank (Dec-25-2022)
    9,919
    World Rank (Jan-07-2022)
    9,919
    Annual Revenue in USD
    13 Million USD
    Annual Operating Income in USD
    -93 Million USD
    Annual Net Income in USD
    -84 Million USD
    Annual Results for Period Ending
    For year ending December-2020
    Headquarters Country
  10. Intersect Ent

    World Rank (Aug-2026)
    9,955
    World Rank (Jan-05-2024)
    9,955
    World Rank (Jul-30-2023)
    9,955
    World Rank (Dec-25-2022)
    9,955
    World Rank (Jan-07-2022)
    9,955
    Market Cap (Jan-07-2022)
    0.91 Billion USD
    Annual Revenue in USD
    107 Million USD
    Annual Operating Income in USD
    -141 Million USD
    Annual Net Income in USD
    -160 Million USD
    Annual Results for Period Ending
    For year ending December-2021
    Headquarters Country
    Company Profile
    Intersect ENT is a Medical Technology company dedicated to advancing the treatment of ear, nose and throat conditions through evidence based innovation. The company annual revenue is approximately 109 million USD and 393 employees as on 2019. The headquarters is in USA.

Share

Ads